Anaphylaxis

What is a placeholder statement?

A placeholder statement is an area of care that has been prioritised by the quality standards advisory committee but for which no source guidance is currently available. A placeholder statement indicates the need for evidence-based guidance to be developed in this area.

Rationale

Recurrence of an anaphylactic reaction can occur a long time after an adrenaline auto-injector is first prescribed and after a person, and their families or carers, are shown how to use the device. People who have been prescribed an adrenaline auto-injector following an anaphylactic reaction are more likely to be able to self-manage anaphylactic reactions if they are provided with ongoing training on how and when to use their adrenaline auto-injector.

The British Society for Allergy and Clinical Immunology (BSCAI) guideline (2016) on prescribing an adrenaline auto-injector includes recommendations on ongoing training in adrenaline auto-injector use. This placeholder statement will be updated when this quality standard is next reviewed.